Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …

Although Crohn's disease (CD) and ulcerative colitis (UC) have been considered as
disorders that affect individuals of European ancestry, the epidemiology of the inflammatory …

Several studies in recent years have demonstrated that gut microbiota–host interactions play
an important role in human health and disease, including inflammatory and cardiovascular …

Chronic inflammatory diseases including human immunodeficiency virus infection, psoriasis,
rheumatoid arthritis, and systemic lupus erythematosus predispose to atherosclerotic …

Inflammation has a strong role in the development of atherosclerotic cardiovascular disease
(ASCVD). Several systemic inflammatory conditions have been linked to an increased risk of …

Evidence from recent epidemiological data suggests that the patient population with
inflammatory bowel disease (IBD) is chronologically aging. As these individuals become …

Abstract Background/Aims While overall rates of colorectal cancer (CRC) have declined in
individuals aged above 50 years of age, this decline has not been seen in younger …

Background & Aims 50% to 80% Crohn's disease (CD) and 10% to 30% ulcerative colitis
(UC) patients require surgery over their lifetime. Biologic therapies may alter this natural …

Atherosclerosis and its fearsome complications represent the first cause of morbidity and
mortality worldwide. Over the last two decades, several pieces of evidence have been …

Background & Aims Population-based studies have suggested an increased risk of acute
arterial events (AAEs) in patients with inflammatory bowel disease (IBD). We aimed to …